Basic Clobetasol Information

• INN (International Nonproprietary Name): Clobetasol Propionate
• Brand Names Available In United Kingdom: Dermovate, Clarelux, Clarelux Foam, generic clobetasol propionate 0.05% cream and ointment
• ATC Code: Not Specified
• Forms & Dosages: Cream, ointment, scalp products, foam; typical concentration 0.05%
• Manufacturers In United Kingdom: Not Specified
• Registration Status In United Kingdom: Prescription‑Only Medicine (POM) under MHRA oversight
• OTC / Rx Classification: Prescription‑Only Medicine (POM)

Critical Warnings & Restrictions (Safety First)

Clobetasol is a very potent topical corticosteroid and must be used with care under medical supervision.

It is a prescription‑only medicine regulated by the MHRA and should only be used exactly as your prescriber or pharmacist advises.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Pregnancy and Breastfeeding — use only if the potential benefit justifies potential risk to the fetus or infant.

Children and Adolescents — avoid routine use; specialist dermatology supervision is required due to HPA‑axis risks and growth concerns.

Elderly — thinner skin increases absorption and risk of local and systemic adverse effects; monitor carefully.

Patients With Diabetes, Widespread Skin Damage Or Systemic Infection — need increased monitoring for skin infections, glucose control and signs of systemic corticosteroid effects.

Interaction With Activities (Driving, Workplace Safety Under UK Law)

Topical clobetasol rarely impairs driving ability.

Systemic effects such as dizziness, visual disturbance or adrenal suppression are possible with extensive use and may affect the ability to operate machinery.

If you feel unwell, lightheaded or visually impaired do not drive and seek healthcare advice.

Q&A — “Can I Drive After Taking It In The UK?”

Usually you can drive after using clobetasol topically.

If you feel dizzy, faint, or otherwise unwell after application, do not drive and contact your prescriber or pharmacist.

• Red Flags Requiring Urgent Review:
• Worsening rash or rapid spread of skin lesions
• Systemic symptoms such as fever, severe fatigue or weight loss
• Signs of secondary infection — increased pain, pus, swelling or warmth
• New rash on the face or around the eyes
• Symptoms suggesting adrenal suppression — persistent tiredness, dizziness, low blood pressure

Usage Basics (INN, Brands, Legal Classification)

Clobetasol propionate is the INN for this very potent topical corticosteroid, most commonly at 0.05% strength.

Common UK brands include Dermovate cream and ointment and Clarelux foam, alongside generic clobetasol propionate 0.05% products.

Formulations on the UK market are cream, ointment, scalp preparations and foam/solution for hair‑bearing areas.

INN And Brand Names Available In The UK

INN: Clobetasol Propionate.

Brands: Dermovate, Clarelux, Clarelux Foam, generic clobetasol propionate 0.05% preparations.

Legal Classification (POM, P, GSL) And Prescribing Context

Clobetasol is a Prescription‑Only Medicine (POM) regulated by the MHRA and cannot legally be supplied over the counter without a prescription.

Prescribers include GPs, dermatology clinics and private prescribers; NHS prescriptions are commonly issued electronically.

Repeat or long‑term repeat dispensing is not appropriate for potent topical steroids; review is required before further supply.

When creating product pages, use product information template fields such as INN, forms and dosages and reference MHRA SPCs for licence details.

Dosing Guide (NHS‑Aligned)

Clobetasol is a very potent topical steroid and the dose must be as prescribed.

Apply a thin film to affected areas once or twice daily, following prescriber instructions.

Standard Regimens (Typical NHS Guidance)

Typical maximum continuous duration is short, usually limited to 2–4 weeks for most indications unless supervised by a specialist.

Use the lowest effective potency and duration to control the flare.

Fingertip Units (FTU): one adult FTU (from the fingertip to the first crease) approximates the amount needed to cover two adult palms.

Adjustments For Comorbidities (Liver Disease, Diabetes, Children, Elderly)

Children, the elderly and those with large area or occluded applications require specialist oversight due to the risk of HPA‑axis suppression.

Diabetic patients using large areas should monitor glucose control and be alert for skin infections.

Q&A — “What If I Miss A Dose?”

Apply the missed dose as soon as you remember.

Do not apply double doses to make up for a missed application.

• Checklist:
• Maximum continuous duration: usually 2–4 weeks.
• Plan for prescriber review before any further courses.
• Record amount used and areas treated for review.

Interaction Chart (Drugs, Food, Lifestyle)

Topical clobetasol has minimal direct food interactions but lifestyle factors can influence skin healing.

Avoid alcohol misuse as chronic heavy drinking may impair skin repair and complicate steroid adverse effects.

Food And Drinks (Alcohol, Topical Products)

There are no specific food or drink restrictions, but excessive alcohol and poor nutrition may slow recovery.

Avoid applying multiple potent topical agents to the same area unless advised by a clinician — for example combining with calcipotriol needs specialist advice.

Common Drug Conflicts (Cautions From MHRA Yellow Card/Interaction Reports)

Systemic interactions are rare for topical use but may occur with extensive damaged skin and absorption.

Monitor for additive HPA‑axis suppression if the patient is taking systemic corticosteroids.

Concomitant use of immunosuppressants and biologics increases infection risk and requires clinician review.

Report suspected adverse reactions via the MHRA Yellow Card scheme and seek medical advice for serious events.

User Reports & Trends (Patient Experience & Sentiment)

Patients commonly report rapid symptom relief after short courses of clobetasol but worry about long‑term effects.

Frequent themes on NHS pages, Patient.info and parenting forums include concern about skin thinning, rebound flares and steroid dependence.

Common searches include brand queries and safety worries about long‑term use on the face or scalp.

• Top Six Patient Concerns:
• Skin thinning and stretch marks after long use.
• Rebound or withdrawal flares when stopping.
• Safety for face and genital application.
• Use in children and long‑term growth effects.
• Confusion over potency rankings and brand names.

Anonymised forum snippet: “Dermovate cleared my plaques in days but my GP warned about stopping quickly to avoid rebound.”

Encourage patients to bring a checklist of questions to appointments, including duration used, areas treated and previous steroid exposure.

Access & Purchase Options (UK Pharmacies & E‑Services)

Clobetasol is usually obtained by prescription from a GP, dermatology clinic or private prescriber and collected from community pharmacies or dispensed by clinics.

Electronic prescriptions allow NHS online pharmacies and home delivery services to supply licensed products.

High‑Street Chains: Boots, LloydsPharmacy, Superdrug

These chains dispense clobetasol on presentation of a valid prescription and provide pharmacist counselling at collection.

Online Pharmacies And NHS E‑Prescriptions

Only use MHRA‑registered and GPhC‑registered online pharmacies and check for pharmacist counselling availability.

Order Checklist: verify POM requirement, check pharmacy GPhC registration, keep patient information leaflet and check batch/expiry on receipt.

In our online pharmacy, clobetasol is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Mechanism & Pharmacology (Simple + Clinical Terms)

How It Works For Patients: Clobetasol is a very potent topical steroid that reduces inflammation, itch and scaling by suppressing the local immune response.

It often eases symptoms within days but is intended for short courses to reduce risk.

Simplified Explanation For Patients

Clobetasol binds to glucocorticoid receptors in the skin to reduce inflammatory mediators and slow skin cell turnover.

Overuse can lead to thinning of the skin and other local effects.

Clinical Pharmacology For Clinicians

High glucocorticoid receptor affinity with anti‑inflammatory and antiproliferative effects is characteristic.

Factors increasing absorption include thin skin, occlusion, damaged skin and larger surface area applications.

• Key Points:
• Potency Class: Very potent (Class 1).
• Onset Of Action: Often within days.
• Absorption Factors: Skin thickness, occlusion, surface area, damaged skin.
• Systemic Risk: HPA‑axis suppression possible with extensive/occluded use.

Indications & Off‑Label Uses (MHRA‑Approved Vs Common Practice)

Licensed indications include severe inflammatory dermatoses responsive to potent topical steroids, used for short courses.

Examples include severe plaque psoriasis, lichen planus, discoid lupus and severe eczema flares when lesser potencies are insufficient.

MHRA‑Approved Uses

Use in focal, severe inflammatory skin conditions where rapid control is needed and benefit outweighs risk for a limited period.

Off‑Label Practices In NHS/Private Care

Off‑label uses may include refractory scalp psoriasis where specialist formulations or application methods are used, and focal severe dermatitis under secondary care supervision.

Off‑label prescribing should be documented, justified and include informed consent with a monitoring plan and follow‑up date.

Key Clinical Findings (Major UK & EU Studies 2022–2025)

When summarising evidence prioritise UK and EU randomised trials, MHRA safety surveillance and guidance from dermatology societies.

Structure evidence into efficacy, safety and comparative outcomes against other potent topical agents.

Recent literature trends (2022–2025) emphasise limited‑duration regimens, steroid‑sparing strategies and increased reporting of misuse online.

Suggested Subsections For A Summary:

• Efficacy — short‑term plaque clearance rates and time to symptom relief.
• Safety — adverse event rates including local atrophy and systemic suppression cases.
• Comparators — trials versus other potent steroids or non‑steroidal alternatives.

Always cite NICE or British Association of Dermatologists guidance where applicable and link to MHRA SPCs for product‑specific safety statements.

Alternatives Matrix (NHS Prescribing Alternatives)

Consider lower‑potency topical corticosteroids, topical calcineurin inhibitors, vitamin D analogues, emollients, phototherapy and systemic agents for severe disease.

Choice depends on site, severity, patient age and comorbidities.

Comparison Table (Potency, Indications, Monitoring)

Pros And Cons Checklist

• Limited Plaque — consider potent steroid short course.
• Facial Or Flexural Involvement — prefer non‑steroidal options or lower potency under specialist advice.
• Widespread Disease — consider systemic therapy or phototherapy; refer to dermatology.

Plan steroid‑sparing step‑up/step‑down strategies and refer when control is inadequate or safety concerns arise.

Common Questions (High‑Value Patient FAQs)

• How Long Can I Use Dermovate/Clobetasol?

  Short courses only; typically 2–4 weeks continuous use unless under specialist care and with monitoring.

• Is Clobetasol Safe On The Face Or Genitals?

  Generally avoid facial and genital application unless directed by a specialist due to increased absorption and risk of atrophy.

• Will It Stain Clothes Or Transfer?

  Ointments are greasier and may leave residue on clothing; creams are less likely to transfer but allow time to absorb before dressing.

• Can Children Use Clobetasol?

  Only under specialist dermatology advice; paediatric dosing and duration differ because of systemic absorption and growth concerns.

Short Micro‑FAQ — Steroid Withdrawal Signs: Watch for worsening rash, redness beyond original area, or systemic symptoms after stopping and contact your GP or dermatologist.

For personalised advice consult your GP or pharmacist and refer to the MHRA SPC or NHS guidance for full information.

NHS Cost & Access Comparison Table (Prices, Charges, Regional Differences)

Cost Checklist For Patients: check prescription exemptions, consider prepayment certificates and ask local pharmacy about dispensing options and charges.

Authors should verify current NHS fees at publication time for exact per‑item charges.

Registration & Regulation (MHRA, NHS Prescribing Framework)

The MHRA licences medicines, publishes SPCs and operates adverse‑event surveillance via the Yellow Card scheme.

Always consult the MHRA SPC for formulation‑specific contraindications, warnings and dosing before publication.

MHRA Approval Process And SPC Use

SPCs are the authoritative source for licensed indications, contraindications and safety information for each marketed product.

Cite the MHRA SPC for product‑specific details and check for licence updates prior to publishing content.

NHS Prescribing Governance And Electronic Prescribing

Clobetasol is POM; NHS e‑prescriptions support electronic transmission to pharmacies and require documented indication and duration in primary care records.

Prescribers should avoid routine repeats for potent topical steroids and escalate to secondary care when specialist management is needed.

• Definitions:
• MHRA — Medicines and Healthcare products Regulatory Agency.
• SPC — Summary Of Product Characteristics.
• POM — Prescription‑Only Medicine.
• GPhC — General Pharmaceutical Council.

Storage & Handling (UK Household Guidance)

Store clobetasol at room temperature away from heat and humidity and out of reach of children and pets.

Avoid leaving tubes or tubs in steamy bathrooms; condensation can degrade the product.

Household Storage (Cold/Damp Climate Advice)

Keep in original packaging and check the expiry date before use.

Follow the SPC or packaging for any “use within X months after opening” guidance.

Guidance From NHS And Pharmacists (Disposal, Travel)

For travel, carry in original packaging and bring a copy or photo of your prescription for cross‑border queries.

Do not flush or dispose of loose tubes in household waste; return unused or expired medicines to a pharmacy for safe disposal.

• Household Safety Checklist:
• Secure storage out of reach of children.
• Check expiry and batch number on receipt.
• Return unused medicine to pharmacy for disposal.

Guidelines For Proper Use (Pharmacist Counselling & NHS Safety Advice)

Pharmacist counselling should confirm the indication, duration and demonstrate the amount using an FTU.

Discuss site‑specific cautions for face, flexures and genitals and explain occlusion risks and infection signs.

UK Pharmacist Counselling Style And Key Counselling Points

• Confirm expected duration and arrange review—typically within 2–4 weeks.
• Show amount using Fingertip Unit and explain frequency (once or twice daily as prescribed).
• Advise that ointments are greasier and creams absorb faster; allow time to dry before dressing.

NHS Patient Safety Advice And Follow‑Up Triggers

Contact prescriber if redness, increasing pain, spreading rash, fever, new rash elsewhere or signs of adrenal suppression occur.

Provide a short “What To Tell Your GP” prompt for patients returning after use, including areas treated, duration and any side effects noted.

Delivery Across United Kingdom